China's Brii Biosciences jumps, says will up investment on COVID-19 virus therapy

Brii Biosciences

08/09/2021 06:58

** Shares of Chinese biotechnology group Brii Biosciences
Ltd  2137.HK  jump 7.3% to HK$45.50, the highest since listing
on July 13
    ** Stock is on course for a fourth straight session of gains
    ** Brii says it is committing an additional $100 mln
investment to advance global regulatory filings and commercial
efforts for its investigational combination therapy on
SARS-CoV-2, the virus that causes COVID-19  urn:newsml:reuters.com:*:nFWN2Q906D
    ** Beijing-based company says the additional investment will
be funded from the proceeds raised from the pre-IPO investments
undertaken by various investors
    ** The Hong Kong Hang Seng Commerce & Industry Index  .HSNC 
climbs 0.1%, and the healthcare index  .HSCIH  eases 0.8%
    ** The Hang Seng China Enterprises Index  .HSCE  and the
benchmark index  .HSI  both slip 0.2%
    

 (Reporting by Donny Kwok)
 ((donny.kwok@thomsonreuters.com))